A new study reports that a single infusion of a controversial drug provided rapid relief for severe depression, with symptoms improving within hours. The treatment marks a significant departure from standard antidepressants, which often take weeks to become effective. Researchers are cautiously optimistic, noting the potential for this therapy to help patients who have not responded to other treatments.
The study’s findings offer hope for millions suffering from treatment-resistant depression, but experts emphasize the need for further research on long-term safety and efficacy. The exact mechanism remains under investigation, but early results show promise for rapid intervention in acute cases.